Determination of the global fibrinolytic state

Blood Coagulation and Fibrinolysis

Volumn 18, Issue 5, 2007, Pages 479-487

  Stief, Thomas W ^a   Fröhlich, Sabrina ^a   Renz, Harald ^a  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

Clot lysis assay; Fibrinolysis; Fibrinolysis parameters assay; Neutrophils; Polymorphonuclear neutrophils

Indexed keywords

ALBUMIN; ARGININE; C REACTIVE PROTEIN; FIBRINOGEN; TOSYLCHLORAMIDE SODIUM; TRANEXAMIC ACID; UROKINASE;

ARTICLE; BLOOD CLOT LYSIS; FIBRINOLYSIS; HUMAN; LEUKOCYTE COUNT; NEUTROPHIL; PARTIAL THROMBOPLASTIN TIME; PLASMA; PRIORITY JOURNAL; PROTHROMBIN TIME; THROMBOCYTE COUNT; TURBIDITY;

BLOOD COAGULATION TESTS; BLOOD PROTEINS; CHLORAMINES; FIBRINOLYSIS; HUMANS; LEUKOCYTE COUNT; OXIDATION-REDUCTION; PLATELET COUNT; TOSYL COMPOUNDS;

EID: 34250823431     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e3281ee6f47     Document Type: Article

References (21)

1. Collen D, Lijnen HR. The fibrinolytic system in man. Crit Rev Oncol Hematol 1986; 4:249-301.
2. Kwaan HC, Astrup T. Demonstration of cellular fibrinolytic activity by the histochemical fibrin slide technique. Lab Invest 1967; 17:140-145.
3. Langleben D, Moroz LA. Interspecies variation in the cellular phase of blood fibrinolytic activity. Proc Soc Exp Biol Med 1991; 196:270-272.
4. Loike JD, Sodeik B, Cao L, Leucona S, Weitz JI, Detmers PA, et al. CD11c/CD18 on neutrophils recognizes a domain at the N terminus of the A alpha chain of fibrinogen. Proc Natl Acad Sci U S A 1991; 88:1044-1048.
5. Ryan TJ, Lai L, Malik AB. Plasmin generation induces neutrophil aggregation: dependence on the catalytic and lysine binding sites. J Cell Physiol 1992; 151:255-261.
6. Cao D, Mizukami IF, Garni-Wagner BA, Kindzelskii AL, Todd RF 3rd, Boxer LA, Petty HR. Human urokinase-type plasminogen activator primes neutrophils for superoxide anion release. Possible roles of complement receptor type 3 and calcium. J Immunol 1995; 154:1817-1829.
7. Gross TJ, Leavell KJ, Peterson MW. CD11b/CD18 mediates the neutrophil chemotactic activity of fibrin degradation product D domain. Thromb Haemost 1997; 77:894-900.
8. 2/hv). Clin Appl Thromb Hemost 2000; 6:22-30.
9. Moir E, Booth NA, Bennett B, Robbie LA. Polymorphonuclear leucocytes mediate endogenous thrombus lysis via a u-PA-dependent mechanism. Br J Haematol 2001; 113:72-80.
10. Varma MR, Varga AJ, Knipp BS, Sukheepod P, Upchurch GR, Kunkel SL, et al. Neutropenia impairs venous thrombosis resolution in the rat. J Vasc Surg 2003; 8:1090-1098.
11. Stief TW. In vitro-simulation of therapeutic thrombolysis by microtiter plate clot-lysis assay. Clin Appl Thromb Hemost 2006; 12:21-32.
12. Fareed J, Hoppensteadt DA, Leya F, Iqbal O, Wolf H, Bick R. Useful laboratory tests for studying thrombogenesis in acute cardiac syndromes. Clin Chem 1998; 44:1845-1853.
13. Amiral J, Malmejec A, Gin H, Pannell R, Vissac AM, Seigneur M, et al. Evaluation of the fibrinolytic potential on plasma: physiological and pathological variations, and associations with cardiovascular disease risk factors. Fibrinol Proteol 1999; 13 (Suppl 1):1-10.
14. Guldiken S, Turgut B, Demir M, Arikan E, Kara M, Vural O, et al. The effects of rosiglitazone treatment on the fibrinolytic system in patients with type 2 diabetes mellitus. Clin Appl Thromb Hemost 2006; 12:55-60.
15. Sucak GT, Acar K, Sucak A, Kirazli S, Haznedar R. Increased global fibrinolytic capacity as a clue for activated fibrinolysis in preeclampsia. Blood Coagul Fibrinolysis 2006; 17:347-352.
16. Stief TW, Hinz F, Kurz J, Doss MO, Kretschmer V. A simple screening assay for certain fibrinolysis parameters (FIPA). Thromb Res 2000; 97:231-237.
17. 2x̄ test - the corrected chi-square comparison against the control-mean. Clin Appl Thromb Hemost 2007; 13:73-100.
18. Ichinose A, Fujikawa K, Suyama T. The activation of pro-urokinase by plasma kallikrein and its inactivation by thrombin. J Biol Chem 1986; 261:3486-3489.
19. van Giezen JJ, Chung-A-Hing JE, Vegter CB, Bouma BN, Jansen JW. Fibrinolytic activity in blood is distributed over a cellular and the plasma fraction which can be modulated separately. Thromb Haemost 1994; 72:887-892.
20. Witko V, Nguyen AT, Descamps-Latscha B. Microtiter plate assay for phagocyte-derived taurine-chloramines. J Clin Lab Anal 1992; 6:47-53.
21. Stief TW, Schorlemmer HU, Beck-Speier I, Doss MO. PAI-2 inhibits the chemiluminescence of phagocytes and suppresses autoimmunity. Fibrinolysis Proteolysis 1999; 13:245-251.